- Subjects with end-stage renal disease
- Subjects need hemodialysis 3 times weekly
- Subjects with evidence or history of clinically significant disease, excluding those
common for subjects with End-Stage Renal Disease (ESRD).
- Subjects with any condition possibly affecting drug absorption.
- Subjects with malignancies with the exception of adequately treated basal cell
carcinoma of the skin.